Background the 24-h ambulatory blood pressure (Abp) is a stronger predictor of cardiovascular disease than conventional blood pressure (Cbp), but it remains unclear how it compares with "usual" blood pressure (Ubp), estimated after Cbp has been corrected for regression dilution bias (rDb).
Throughout middle and old age and in all ethnic groups, blood pressure is strongly and directly related to the risk of fatal and nonfatal cardiovascular disease. 1, 2 Estimates of the strength of the association of blood pressure with cardiovascular disease crucially depend on the precision of the methods used to measure blood pressure. Until recently, most prospective studies have predicted cardiovascular disease outcomes from blood pressure measurements recorded on a single occasion. Conventional blood pressure (CBP) measurements are subject to substantial random fluctuations, partly due to measurement error and the effect of the observer on the individual, 3 and partly due to biologic variability, such as circadian or seasonal variation, or changes in blood pressure associated with age, onset of disease, or treatment. Consequently, estimation of cardiovascular risk associated with blood pressure recorded on a single occasion results in prospective cohort studies in a systematic underestimation of the strength of the association of blood pressure with cardiovascular disease. This phenomenon is known as "regression dilution bias" (RDB). [4] [5] [6] [7] Although the mean of two blood pressure measurements reduces the impact of RDB, it does not eliminate it and repeat blood pressure measurements are required at some later visit to quantify and correct for this bias. Correction for RDB is carried out by estimation of the "usual" blood pressure (UBP), using the mean values of remeasurements of blood pressure in baseline-defined groups to define the degree of "shrinkage" or the regression dilution ratio at about the midpoint of follow-up and to correct the coefficients relating cardiovascular events to blood pressure in such studies. 5 Twenty-four hour ambulatory blood pressure (ABP) monitoring allows measurement of blood pressure throughout the whole day in individuals engaged in their usual activities. 8 ABP articles Usual vs. Ambulatory Blood Pressure measurements have high reproducibility, are not subject to digit preference, and avoid the transient rise of a patient's blood pressure in response to the observer referred to as the "white-coat" effect. 9 To our knowledge, no previous study has compared the predictive value for cardiovascular outcomes of CBP, UBP, and 24-h ABP. We investigated the strength of the association of these different measurements of blood pressure with cardiovascular disease outcomes in a prospective cohort study.
Methods
Study population. From August 1985 to December 2004, we recruited a random sample of 2,813 participants from a geographically defined area in Northern Belgium into the Flemish Study of Environment, Genes and Health Outcomes (FLEMENGHO). 10 The overall participation rate in the study was 64.3%. Among the 2,813 participants, 1,646 were excluded because intentionally their nighttime ABP had not been measured (n = 1,596), or because their daytime (n = 27) or nighttime (n = 23) ABPs were based on the average of <10 or 5 readings, respectively. The present analysis was restricted to 1,167 participants with complete data (Figure 1 ). All participants provided informed consent to a protocol that was approved by the University of Leuven Ethics Committee.
Blood pressure measurement. Trained observers, who participated in a previously described quality control program, 11, 12 visited the participants at home at baseline and at follow-up visits. At each visit, CBP was measured five times consecutively, after the subject had rested for at least 5 min in the seated position. All participants had systolic and diastolic (phase 5) blood pressures recorded to the nearest 2 mm Hg. For participants with an arm circumference of <32 cm, a standard cuff, with an inflatable bladder with a length of 22 cm and a width of 12 cm was used to measure blood pressure. For participants with a greater arm circumference, cuffs with a 35 × 15 cm bladder were used. The mean values of five separate CBP readings recorded at each visit were used in the analysis. All participants had their height and weight recorded, from which body mass index was calculated.
All participants were asked to complete a questionnaire seeking information about their medical history, smoking and drinking habits, and use of medications. The participants provided a venous blood sample for the measurement of serum total cholesterol. Oscillometric SpaceLabs 90207 monitors (SpaceLabs, Redmond, WA), fitted with the same cuff size as for the CBP measurements were used to obtain blood pressure readings at intervals of 20 min from 8 am to 10 pm and every 45 min from midnight to 6 am. The calibration of these devices was checked every 3 months against a mercury column. We averaged the ABP readings over 24 h, while weighting for the time interval between consecutive readings. Repeat measurements of CBP were available at two, three, four, or more occasions in 61, 413, 277, and 326 participants, respectively. The ABP was measured only once at baseline, on average within 3 days (5th to 95th percentile interval, 0-18 days) of the corresponding CBP.
Ascertainment of outcome.
We ascertained the vital status of all study participants from baseline until 30 June 2005 via the National Population Registry (Rijksregister) in Brussels, Belgium. We obtained the International Classification of Disease codes for the immediate and underlying causes of death from the Flemish Registry of Death Certificates (Ministry of the Flemish Community, Brussels, Belgium). We collected additional information on the subjects' medical history and cause of death from the general practitioners, hospital records, and at 1,077 follow-up visits between August 1985 and June 2005, using the same standardized questionnaire as that administered at baseline. Physicians blinded with regard to the participants' blood pressure level validated the diseases reported via the death certificates or via the questionnaires against the records held by general practitioners and/or hospitals. 10 Coronary events included fatal and nonfatal myocardial infarction, coronary revascularization, and fatal ischemic heart disease other than acute myocardial infarction. Cardiac events included fatal and nonfatal heart failure, coronary events, and sudden death. Fatal and nonfatal cardiovascular events included the cardiac endpoint, fatal and nonfatal stroke not including transient ischemic attacks, fatal peripheral arterial disease, aortic aneurysm, cor pulmonale, and pulmonary embolism. For all end points, individuals were censored from further analysis after the occurrence of a first event.
Statistical analysis. For database management and statistical analysis, we used SAS software (SAS Institute, Cary, NC), version 9.1.3. We compared means and proportions, using the standard normal z-test and the χ 2 -statistic, respectively.
To explore the plausibility of the Cox model, we plotted incidence rates of cardiovascular events by fourths of the blood pressure distributions, while standardizing by the direct method for sex and age (<40, 40-60, ≥60 years). Because these exploratory analyses revealed that there was no significant articles Usual vs. Ambulatory Blood Pressure association of cardiovascular outcome with diastolic blood pressure (P for trend across quartiles >0.10), we restricted our analysis to systolic blood pressure. Cox regression models were used to calculate hazard ratios, while adjusting for sex, age, body mass index, smoking and drinking, treatment with antihypertensive drugs, and serum total cholesterol. The proportional hazards assumption was checked using the Kolmogorov-type supremum test, as implemented in the PROC PHREG procedure of the SAS package. In addition, Cox regression models were used to estimate the probability of the 10-year incidence of cardiovascular events. We estimated the correction factor for RDB from the CBP measurements recorded at baseline and at median follow-up in 723 untreated participants, who remained free of cardiovascular disease. These 723 subjects were classified into quartiles of CBP at baseline. The mean values of the baseline-defined quartiles were used to estimate the mean difference (interquartile range) in systolic CBP between the lowest and highest quartiles at baseline (∆ b ) and follow-up (∆ fu ). The ratio of the two differences (∆ fu /∆ b ) was then used to estimate the regression dilution ratio. To obtain each participant's usual systolic blood pressure (UBP i ), we applied the regression dilution ratio derived from 723 untreated participants, who were free of cardiovascular disease, to each of the 1,167 participants' CBP at baseline. UBP i was BP bm + ((∆ fu /∆ b ) × (BP bi − BP bm )), where UBP i indicates each individual's computed usual blood pressure, BP bm is the average systolic CBP at baseline and BP bi indicates the baseline CBP in each of the 1,167 participants (Figure 2) . 6 Furthermore, as previously suggested by Clarke, 5 we estimated RDB, using two alternative approaches. First, we regressed the blood pressure at follow-up on the baseline blood pressure. Second, using sequential CBP measurements in 222 untreated subjects free of cardiovascular disease, we estimated the regression dilution rate per year. Regression dilution rate was computed by regressing the sequentially observed correction factors on median follow-up time at each available contact. The hazard ratios in Cox regression in 1,167 participants were corrected for RDB by multiplying the logarithm of the hazard ratios by 1/regression dilution ratio (referred to as a correction factor).
results

Baseline characteristics of the participants
The 1,167 participants included 592 women (50.7%) and 267 hypertensive patients (22.9%), of whom 173 were medically treated (64.8%). Table 1 shows that compared with women, men had higher CBP, and 24-h ABP, and higher serum levels of total cholesterol. The prevalence of smoking was also higher in men than in women (35% vs. 28.6%), as was the prevalence of alcohol consumption (29.2% vs. 6.2%), respectively. Among smokers, the median tobacco use was 15 cigarettes/day (interquartile range, 10-22). Among drinkers, the median daily alcohol consumption was 20 g (10-31). Values are mean (±s.d.) or number of subjects (%). All sex differences were statistically significant (P < 0.05), except for age (P = 0.80), diabetes (P = 0.35) and body mass index (P = 0.42). Figure 3 shows significant positive associations of all cardiovascular end points with systolic CBP (P for trend = 0.005), systolic UBP (P = 0.005), and 24-h systolic ABP (P = 0.02). Table 2 shows that in Cox models only adjusted for sex and age, systolic blood pressure was a significant predictor of cardiovascular mortality and of cardiovascular and cardiac events on 24-h ABP recording (0.0003 ≤ P ≤ 0.0005), but not on CBP measurement. These associations were not materially altered by additional adjustment for body mass index, total cholesterol, smoking, alcohol consumption, and antihypertensive treatment ( Table 2) . For each 10 mm Hg increment in 24-h systolic ABP, the risk of cardiovascular mortality, and of cardiovascular and cardiac events increased by 38% (P = 0.0009), 27% (P = 0.0008), and 33% (P = 0.0006), respectively. The corresponding risk estimates for CBP were 10% (P = 0.21), 9% (P = 0.12), and 14% (P = 0.06), reaching borderline significance only for cardiac events ( Table 2 ). The hazard ratios for UBP were intermediate between those for 24-h ABP and CBP, but by definition had the same significance levels as those for CBP ( Table 2) . In models, which included either CBP or UBP in addition to 24-h ABP, only 24-h ABP was a significant predictor of cardiovascular outcomes. articles Usual vs. Ambulatory Blood Pressure Figure 4 illustrates the 10-year multivariate-adjusted risk of cardiovascular mortality, and of cardiovascular and cardiac events associated with each type of systolic blood pressure.
Comparison of the parameter estimates showed that the risk of cardiovascular mortality (P = 0.03), and of cardiovascular (P = 0.05) and cardiac (P = 0.10) events tended to be higher per unit increase in 24-h ABP than CBP. Comparisons of the parameter estimates between the 24-h ABP and UBP did not reach statistical significance (0.08 ≤ P ≤ 0.22). For all end points, the −2 log likelihood statistics for fully adjusted models containing UBP did not differ from the −2 log likelihood values associated with similarly adjusted models containing CBP. The differences between −2 log likelihood statistics associated with the fully adjusted models containing ABP and those containing either CBP or UBP were statistically significant (P ≤ 0.0073).
sensitivity analyses
In a subgroup of 1,077 participants with at least one follow-up assessment of blood pressure and cardiovascular risk factors, we adjusted our Cox models for the time-dependent change in risk profile (body mass index, smoking and drinking habits, total cholesterol, and antihypertensive treatment). The timedependent adjustment for the aforementioned covariates did not alter our results and in particular did not decrease the predictive power of the 24-h systolic ABP.
In 222 participants remaining free from cardiovascular events and antihypertensive treatment, four follow-up visits were available. The estimated regression dilution rate was 0.01/year, starting from the baseline correction factor of 1.57 (Table 3) . Using this approach, we confirmed that the correction factor for blood pressure values obtained at a 6.5-year interval was 1.63. The correction factor for median duration of follow-up (13 years) was 1.7. Thus, results were consistent, irrespective of the method to correct for RDB.
discussion
This study showed that 24-h ABP is a better predictor of cardiovascular disease outcomes than the so-called UBP, which adjusts CBP for RDB. The results of this study confirm the conclusions of previous studies, which reported that in both The interquartile range is the difference between the means of systolic blood pressure between the bottom and top quartiles. ∆ b /∆ fu indicates the ratio of the interquartile range at baseline to that at follow-up. The regression dilution rate was computed by regression of the observed correction factors on median follow-up time (7 days, 5.4 years, 11.0 years, and 14.8 years). The number of subjects free of cardiovascular disease and blood pressure lowering drugs was 222. middle-aged and older people, systolic blood pressure is a better predictor of cardiovascular complications than diastolic blood pressure, 1, 2 and that ABP is also superior to CBP for each cardiovascular outcome. Indeed, the results of this study were true not only for fatal cardiovascular events, but also for fatal and nonfatal cardiovascular end points combined. Over a century ago, Sir Francis Galton was the first to describe the phenomenon of the so-called regression to the mean, in which values at the extremes of a distribution are likely to be closer to the mean on remeasurement. 13 More recently, it was observed, that the magnitude of the bias is greater at longer intervals between measurements. 5 Blood pressure measurements showing less variation about the population mean are believed to provide a more precise estimate of the participant's "real" blood pressure or UBP. 14, 15 Because the magnitude of this bias increases at longer intervals between measurements, it is important to correct for bias for the appropriate duration of follow-up in prospective studies.
Cardiovascular disease and antihypertensive medications reduce blood pressure. In this study, we therefore calculated the correction factor in 723 untreated participants who remained free from cardiovascular disease. Next, we applied the so-obtained correction factor to adjust the relation between cardiovascular outcome and systolic CBP at baseline in all 1,167 participants. We estimated that any such relation should be 63% steeper for the systolic UBP than CBP. Furthermore, using data from repeated assessments, we calculated the regression dilution rate of 0.01/year for systolic blood pressure and used this to estimate the regression dilution ratio at median follow-up. We then compared the predictive value of CBP, UBP, and ABP measurements and found that for all endpoints under study, 24-h ABP, both in minimally and fully adjusted analyses was a significant predictor of cardiovascular disease outcomes and remained so even after additional adjustment for CBP or UBP. In the sensitivity analyses, we also adjusted this relation for time-dependent changes in other cardiovascular risk factors, including body mass index, smoking and drinking habits, total cholesterol, and antihypertensive treatment. The sensitivity analysis produced consistent results.
The assessment of absolute risk of cardiovascular disease furthermore showed that, for instance for a systolic blood pressure of 140 mm Hg, estimates of absolute risk differed according to the method, by which blood pressure was measured. The 10-year risks of experiencing a fatal or nonfatal cardiovascular event were 4.4% at the age of 50 years, and 10.2% at 60 years, when blood pressure was measured conventionally. Correction for RDB raised these estimates to 4.8 and 11.1%, respectively. However, when risk estimates were derived from 24-h ABP measurement, these values increased to 6.6 and 15.2%.
This study illustrates the value of ABP measurement for the prediction of cardiovascular outcomes and confirms the results of previous studies comparing CBP with ABP measurements for prediction of cardiovascular outcomes in hypertensive patients 16, 17 or random population samples. [18] [19] [20] The Ohasama study followed 1,332 subjects for 10.8 years on average. 18 During that time, 72 cardiovascular deaths occurred. Compared with CBP, ABP was a better predictor of cardiovascular and all-cause mortality and stroke. 18 The ABP monitoring project embedded in the Danish MONICA study followed 1,700 participants for an average time of 9.5 years. 19 During follow-up 174 deaths occurred, 63 of which were due to cardiovascular causes. Both systolic and diastolic ABP were better predictors of total and cardiovascular mortality than CBP. 19 The PAMELA study included 2,051 participants randomly drawn from the population of Monza. 20 During a mean follow-up time of 10.9 years, 186 deaths, of which 56 were cardiovascular, accrued. On the basis of the goodness-of-fit analysis, the Italian researchers stated that ABP was not superior to CBP in predicting mortality, but that the slope of the relation was steeper for ABP than CBP. 20 The PAMELA investigators did not adjust for sex, age, or any other cardiovascular risk factor. 20 None of the aforementioned population studies [18] [19] [20] included intermediate assessments of the participants, which are required to evaluate RDB or to adjust for time-dependent covariates, or accounted for nonfatal cardiac events. This affects the generalizability of their findings, [18] [19] [20] because coronary care units, thrombolysis, and invasive surgical and transluminal arterial procedures drastically reduce the case-fatality rate of cardiac events.
This study must be interpreted within the context of its limitations. First, in comparison with other prospective studies, the number of deaths and incident cardiovascular complications was relatively low. Second, there were no repeat measurements of ABP to assess the RDB associated with ABP. Furthermore, in long-term surveys, the definition of events may be less precise than in short-term studies or trials, in which end points are collected from a single source. Nevertheless, the results of the present study were consistent across all events considered in the analyses.
In conclusion, this study showed that systolic ABP predicted the incidence of fatal and nonfatal cardiovascular complications in a general population over and beyond CBP and UBP. ABP was a stronger predictor than both CBP and UBP. However, correcting CBP for RDB resulted in a steeper slope of events on blood pressure than observed for CBP, but the association with UBP was not statistically significant and did not enhance the prediction of outcome to the level of ABP.
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